Jan 8, 2021, 01:00 AM by User Not Found

Bio-IT World I New hybrid approach identifies existing drugs that could be repurposed to treat SARS-CoV-2 and Cellid signs research contract with the International Vaccine Institute to expedite clinical development of “AdCLD-CoV-19” COVID-19 vaccine. Plus: Illumina and Helix will track the emergence and prevalence of new strains, including the highly transmissible B.1.1.7 variant.

Jan 7, 2021, 11:26 AM by

Panthera’s clinical trial sites are helping to evaluate an alternative AstraZeneca vaccine for people who are unable to have the currently approved Covid-19 vaccines. The treatment is aimed at helping those people with a compromised immune system, who cannot be vaccinated, vaccine hesitant and those who are unlikely to respond to a vaccination.

Jan 7, 2021, 11:26 AM by

Jan 7, 2021, 11:25 AM by

ComputaBio, a US supplier of professional computational biology services, has launched molecular dynamics simulation services for industrial and academic customers to expedite the process of drug design.

Jan 7, 2021, 11:25 AM by

Jan 7, 2021, 01:00 AM by User Not Found

Bio-IT World | When we spoke with the Bio-IT World vendor community, leaders reported working hard to synthesize what 2020 brought us and apply those learnings to 2021. As they each made predictions in their own business areas, some themes arose.

Jan 6, 2021, 18:36 PM by User Not Found

Bio-IT World | Charles River Laboratories acquired Distributed Bio on December 31, 2020. The acquisition marks the culmination of an exclusive partnership between these companies that was initiated in October 2018.

Jan 6, 2021, 01:00 AM by User Not Found

Bio-IT World | Scientists at RMIT University in Melbourne, Australia, have developed a nebulizer for delivering drugs and vaccines to the lungs by generating high-frequency sound waves on a microchip. Serendipitously, the device generates droplets “just the right size”—between 1 and 5 microns—for large molecules such as DNA and antibodies to reach the deep lungs.

Jan 4, 2021, 09:56 AM by User Not Found

Bio-IT World | Illumina and Harvard Pilgrim announce risk sharing for whole genome sequencing, new cryo-EM from Thermo Fisher, LSBio acquires Absolute Antibody, Presearch digitizes hand-written lab notes, and more.

Dec 30, 2020, 01:00 AM by User Not Found

Bio-IT World | Google got ensnared in a controversy over AI ethics when it let go its AI ethicist Timnit Gebru in a dispute over a research paper on large language models she had submitted to a conference.

Dec 29, 2020, 01:00 AM by User Not Found

Bio-IT World | While much of the biotech and life sciences fields shifted to focus energy and efforts into understanding SARS-CoV-2 and the disease it causes, these weren’t the year’s only developments. This year Bio-IT World has covered growing data commons efforts, announced our annual Innovative Practices Award winners, looked at how Big Pharma is doing data science, delved into COVID-19 updates, and much more.

Dec 22, 2020, 01:00 AM by User Not Found

Bio-IT World | TRENDS FROM THE TRENCHES—We are routinely asked questions about Apache Airflow: when to use it, how to get the most out of it, and what to watch out for. Here’s why The BioTeam believes Apache Airflow is one of the most critical tools in the toolbox of a data scientist.

Dec 21, 2020, 01:00 AM by User Not Found

Bio-IT World | Immunai has announced its collaboration with 10x Genomics as one of the first 10x Certified Service Providers. Immunai will leverage 10x’s robust single-cell technologies to map hundreds of cell types and states. By applying its proprietary artificial intelligence and machine learning algorithms, Immunai supports biomarker discovery and insight generation to ultimately power new therapeutic discoveries and accelerate drug development.

Dec 21, 2020, 01:00 AM by User Not Found

Bio-IT World | Funding updates around the life sciences including cash for a handheld mass spec device, Series D for oncolytic immunotherapy, a new company launch in allogenic CAR-NK cells, AI-powered cell classification, a 3-D sequencing platform, and more.

Dec 18, 2020, 01:00 AM by User Not Found

Bio-IT World | Human “helper proteins” aiding the virus, genes linked with disease severity, the potency of neutralizing antibodies, and AI system identifying drugs. Plus: PacBio and Labcorp generate 65,000 genomes and funding from Germany and DARPA.

Dec 16, 2020, 15:54 PM by User Not Found

Bio-IT World | Emedgene has announced a non-exclusive partnership with Illumina and the integration of automated interpretation into Illumina's TruSight Software Suite for rare genetic diseases. Emedgene's Clinical Rare Disease application is one of a portfolio of artificial intelligence (AI)-powered applications for high-throughput genomic interpretation across clinical and research use cases.

Dec 16, 2020, 14:15 PM by

Dec 16, 2020, 14:15 PM by

Dec 16, 2020, 14:15 PM by

Specialist development pharmaceutical company AMZELL B.V has concluded discussions with the FDA ahead of initiating a Phase 3 trial of its new treatment for infantile epileptic disease, AMZ002.

Dec 16, 2020, 14:15 PM by